Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

iCarbonX Raises $106 Million in Series A for Big Health Data

publication date: Jan 21, 2016
iCarbonX, a China AI healthcare big data company started by Dr. Jun Wang, former CEO of BGI, is raising $106 million in a Series A funding round. The funding values iCarbonX at $760 million. The company plans to combine big data, omics (genomics, proteomics, metabolomics, microbiomics), life style information and artificial intelligence. Using AI, the data will be mined to aid drug development and set standards to help people live healthy lives. BGI, formerly known as Beijing Genomics Institute, is the world's largest provider of sequencing services. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital